Nyt fra tidsskrifterne
Ingen søgeord valgt.
45 emner vises.
Liu, X., Wang, Y., Yang, Z., Wu, Z., Li, J., Tong, Z., Li, X., Ren, F., Zhu, X., Jin, M., Mao, G.
BMJ Open, 15.05.2024
Tilføjet 15.05.2024
ObjectiveTo evaluate the effectiveness of standardised antiretroviral therapy (ART) among different HIV subtypes in people living with HIV/AIDS (PLWHA), and to screen the best ART regimen for this patient population. DesignA retrospective cohort study was performed, and PLWHA residing in Huzhou, China, between 2018 and 2020, were enrolled. Setting and participantsData from 625 patients, who were newly diagnosed with HIV/AIDS in the AIDS Prevention and Control Information System in Huzhou between 2018 and 2020, were reviewed. Analysis and outcome measuresData regarding demographic characteristics and laboratory investigation results were collected. Immune system recovery was used to assess the effectiveness of ART, and an increased percentage of CD4+ T lymphocyte counts >30% after receiving ART for >1 year was determined as immunopositive. A multiple logistic regression model was used to comprehensively quantify the association between PLWHA immunological response status and virus subtype. In addition, the joint association between different subtypes and treatment regimens on immunological response status was investigated. ResultsAmong 326 enrolled PLWHA with circulating recombinant forms (CRFs) CRF01_AE, CRF07_BC and other HIV/AIDS subtypes, the percentages of immunopositivity were 74.0%, 65.6% and 69.6%, respectively. According to multivariate logistic regression models, there was no difference in the immunological response between patients with CRF01_AE, CRF07_BC and other subtypes of HIV/AIDS who underwent ART (CRF07_BC: adjusted OR (aOR) (95% CI) = 0.8 (0.4 to 1.4); other subtypes: aOR (95% CI) = 1.2 (0.6 to 2.3)). There was no evidence of an obvious joint association between HIV subtypes and ART regimens on immunological response. ConclusionsStandardised ART was beneficial to all PLWHA, regardless of HIV subtypes, although it was more effective, to some extent, in PLWHA with CRF01_AE.
Læs mere Tjek på PubMedQiu, L., Zhao, L., Wang, B., Yang, L., Cao, C., Lv, M., Xu, M., Hou, M., Wang, X., Wang, Y., Gu, C. P.
BMJ Open, 15.05.2024
Tilføjet 15.05.2024
IntroductionPostoperative pulmonary complications (PPCs) occur frequently in patients undergoing lung surgery under general anaesthesia and are strongly associated with longer postoperative hospital stays and increased mortality. The existing literature has shown that a higher level of preoperative physical activity (PA) plays a positive role in the low incidence of postoperative complications and the quality of life in patients undergoing lung surgery. However, the association between preoperative PA levels and the incidence of PPCs has rarely been studied, particularly in thoracoscopic lung surgery. This study aims to evaluate PA levels in patients undergoing thoracoscopic lung surgery using the International Physical Activity Questionnaire and to investigate the association between PA levels and the incidence of PPCs. Methods and analysisA total of 204 participants aged 18–80 years undergoing thoracoscopic lung surgery (thoracoscopic wedge resection, thoracoscopic segmentectomy and thoracoscopic lobectomy) will be included in the study. The primary outcome is the incidence of PPCs within the first 5 postoperative days. The secondary outcomes include the number of PPCs, the incidence of PPCs 1 month postoperatively, the arterial blood levels of inflammatory markers, the incidence of postoperative adverse events within the first 5 postoperative days, extubation time, unplanned admission to the intensive care unit, postoperative length of stay and mortality 1 month postoperatively. Ethics and disseminationThe study was reviewed and approved by the Research Ethics Committee of the First Affiliated Hospital of Shandong First Medical University on 31 March 2022 (YXLL-KY-2022(014)) and is registered at ClinicalTrials.gov. We plan to disseminate the data and findings of this study in international and peer-reviewed journals. Trial registration numberThe trial has been prospectively registered at the clinicaltrials.gov registry (NCT05401253).
Læs mere Tjek på PubMedCooper, K., Duncan, E., Hart-Winks, E., Cowie, J., Shim, J., Stage, E., Tooman, T., Alexander, L., Love, A., Morris, J. H., Ormerod, J., Preston, J., Swinton, P.
BMJ Open, 15.05.2024
Tilføjet 15.05.2024
ObjectivesTo explore the experience of accessing Long COVID community rehabilitation from the perspectives of people with Long COVID and general practitioners (GPs). DesignQualitative descriptive study employing one-to-one semistructured virtual interviews analysed using the framework method. SettingFour National Health Service Scotland territorial health boards. Participants11 people with Long COVID (1 male, 10 female; aged 40–65 (mean 53) and 13 GPs (5 male, 8 female). ResultsFour key themes were identified: (1) The lived experience of Long COVID, describing the negative impact of Long COVID on participants’ health and quality of life; (2) The challenges of an emergent and complex chronic condition, including uncertainties related to diagnosis and management; (3) Systemic challenges for Long COVID service delivery, including lack of clear pathways for access and referral, siloed services, limited resource and a perceived lack of holistic care, and (4) Perceptions and experiences of Long COVID and its management, including rehabilitation. In this theme, a lack of knowledge by GPs and people with Long COVID on the potential role of community rehabilitation for Long COVID was identified. Having prior knowledge of rehabilitation or being a healthcare professional appeared to facilitate access to community rehabilitation. Finally, people with Long COVID who had received rehabilitation had generally found it beneficial. ConclusionsThere are several patient, GP and service-level barriers to accessing community rehabilitation for Long COVID. There is a need for greater understanding by the public, GPs and other potential referrers of the role of community rehabilitation professionals in the management of Long COVID. There is also a need for community rehabilitation services to be well promoted and accessible to the people with Long COVID for whom they may be appropriate. The findings of this study can be used by those (re)designing community rehabilitation services for people with Long COVID.
Læs mere Tjek på PubMedVasiliki Tsolaki, Ilias I. Siempos
American Journal of Respiratory and Critical Care Medicine , 15.05.2024
Tilføjet 15.05.2024
American Journal of Respiratory and Critical Care Medicine, Volume 209, Issue 10, Page 1179-1180, May 15, 2024.
Læs mere Tjek på PubMedBijan Teja, Megan Berube, Tiago V. Pereira, Anica C. Law, Carly Schanock, Brandon Pang, Hannah Wunsch, Allan J. Walkey, Nicholas A. Bosch
American Journal of Respiratory and Critical Care Medicine , 15.05.2024
Tilføjet 15.05.2024
American Journal of Respiratory and Critical Care Medicine, Volume 209, Issue 10, Page 1219-1228, May 15, 2024.
Læs mere Tjek på PubMedLin Li, Emily Henkle, Brady M. Youngquist, Seungyeon Seo, Kamal Hamed, David Melnick, Christopher J. Lyon, Li Jiang, Adrian M. Zelazny, Tony Y. Hu, Kevin L. Winthrop, Bo Ning
American Journal of Respiratory and Critical Care Medicine , 15.05.2024
Tilføjet 15.05.2024
American Journal of Respiratory and Critical Care Medicine, Volume 209, Issue 10, Page 1246-1254, May 15, 2024.
Læs mere Tjek på PubMedAndrew Gilmore, Justin Ortiz
American Journal of Respiratory and Critical Care Medicine , 15.05.2024
Tilføjet 15.05.2024
American Journal of Respiratory and Critical Care Medicine, Volume 209, Issue 10, Page P5-P7, May 15, 2024.
Læs mere Tjek på PubMedBMC Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Abstract Background Brain-heart infusion agar supplemented with 4 µg/mL of vancomycin (BHI-V4) was commonly used for the detection of heterogeneous (hVISA) and vancomycin-intermediate Staphylococcus aureus (VISA). However, its diagnostic value remains unclear. This study aims to compare the diagnostic accuracy of BHI-V4 with population analysis profiling with area under the curve (PAP-AUC) in hVISA/VISA. Methods The protocol of this study was registered in INPLASY (INPLASY2023120069). The PubMed and Cochrane Library databases were searched from inception to October 2023. Review Manager 5.4 was used for data visualization in the quality assessment, and STATA17.0 (MP) was used for statistical analysis. Results In total, eight publications including 2153 strains were incorporated into the meta-analysis. Significant heterogeneity was evident although a threshold effect was not detected across the eight studies. The summary receiver operating characteristic (SROC) was 0.77 (95% confidence interval [CI], 0.74–0.81). The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic score and diagnostic odds ratio were 0.59 (95% CI: 0.46–0.71), 0.96 (95%CI: 0.83–0.99), 14.0 (95% CI, 3.4–57.1), 0.43 (95%CI, 0.32–0.57), 3.48(95%CI, 2.12–4.85) and 32.62 (95%CI, 8.31-128.36), respectively. Conclusion Our study showed that BHI-V4 had moderate diagnostic accuracy for diagnosing hVISA/VISA. However, more high-quality studies are needed to assess the clinical utility of BHI-V4.
Læs mere Tjek på PubMedBMC Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Abstract Background Diet plays an important role in Helicobacter pylori (HP) infection, and our objective was to investigate potential connections between dietary patterns, specific food groups, and HP infection status in U.S. adults. Methods The data for this study was obtained from the NHANES (National Health and Nutrition Survey) database for the year 1999–2000. This cross-sectional study involved the selection of adults aged 20 years and older who had undergone dietary surveys and HP testing. Factor analysis was employed to identify dietary patterns, and logistic regression models were utilized to assess the association between these dietary patterns and specific food groups with HP infection status. Result Based on the inclusion and exclusion criteria, our final analysis included 2,952 individuals. The median age of participants was 51.0 years, and 48.7% were male. In the study population, the overall prevalence of HP infection was 44.9%. Factor analysis revealed three distinct dietary patterns: High-fat and high-sugar pattern (including solid fats, refined grains, cheese, and added sugars); Vegetarian pattern (comprising fruits, juices, and whole grains); Healthy pattern (encompassing vegetables, nuts and seeds, and oils). Adjusted results showed that the high-fat and high-sugar pattern (OR = 0.689, 95% CI: 0.688–0.690), vegetarian pattern (OR = 0.802, 95% CI: 0.801–0.803), and healthy pattern (OR = 0.717, 95% CI: 0.716–0.718) were all linked to a lower likelihood of HP infection. Further analysis of the high-fat and high-sugar pattern revealed that solid fats (OR = 0.717, 95% CI: 0.716–0.718) and cheese (OR = 0.863, 95% CI: 0.862–0.864) were protective factors against HP infection, while refined grains (OR = 1.045, 95% CI: 1.044–1.046) and added sugars (OR = 1.014, 95% CI: 1.013–1.015) were identified as risk factors for HP infection. Conclusion Both the Vegetarian pattern and the Healthy pattern are associated with a reduced risk of HP infection. Interestingly, the High-fat and High-sugar pattern, which is initially considered a risk factor for HP infection when the score is low, becomes a protective factor as the intake increases. Within this pattern, animal foods like solid fats and cheese play a protective role, while the consumption of refined grains and added sugars increases the likelihood of HP infection.
Læs mere Tjek på PubMedBMC Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Abstract Background Malaria in pregnancy remains a major public health problem in the globe, especially in sub-Saharan Africa. In malaria endemic areas, most pregnant women remain asymptomatic, but malaria could still cause complications on the mother and her offspring; as well as serve as reservoirs to transmit infection. Despite these effects, no attention is given to the diagnosis of asymptomatic Plasmodium infections (APIs) using highly sensitive and specific laboratory diagnostic tools in Ethiopia. Therefore, the goal of this study was to compare the performance of Rapid Diagnostic Test (RDT), microscopy and real-time polymerase chain reaction (RT-PCR) to detect APIs among pregnant women. Methods A health facility based cross -sectional study was conducted among pregnant women attending antenatal care at Fendeka town health facilities Jawi district, northwest Ethiopia from February to March, 2019. A total of 166 participants were enrolled by using convenient sampling technique. Socio-demographic features were collected using a semi structured questionnaire. Dried blood spot (DBS) samples were collected for molecular analysis. Asymptomatic Plasmodium infection on pregnant women was diagnosed using RDT, microscopy and RT-PCR. Descriptive statistics were used to determine the prevalence of APIs. Method comparison was performed, and Cohen’s kappa coefficient (k) was used to determine the degree of agreement among the diagnostic methods. Parasite densities were also calculated. Results The prevalence of API was 9.6%, 11.4% and 18.7% using RDT, microscopy and RT-PCR, respectively. The overall proportion of API was 19.3%. Sensitivity of the RDT was 83.3% as compared with microscopy. Rapid Diagnostic Test and microscopy also showed sensitivity of 50% and 60%, respectively, as compared with RT-PCR. The mean parasite density was 3213 parasites/µl for P falciparum and 1140 parasites/µl of blood for P. vivax. Conclusion Prevalence of API in the study area was high. Both RDT and microscopy had lower sensitivity when compared with RT-PCR. Therefore, routine laboratory diagnosis of API among pregnant women should be given attention and done with better sensitive and specific laboratory diagnostic tools.
Læs mere Tjek på PubMedBMC Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Abstract Brucellosis, a zoonotic disease caused by Brucella species, poses a significant global health concern. Among its diverse clinical manifestations, neurobrucellosis remains an infrequent yet debilitating complication. Here, we present a rare case of neurobrucellosis with unusual presentations in a 45-year-old woman. The patient’s clinical course included progressive lower extremity weakness, muscle wasting, and double vision, prompting a comprehensive diagnostic evaluation. Notable findings included polyneuropathy, elevated brucella agglutination titers in both cerebrospinal fluid and blood, abnormal EMG-NCV tests, and resolving symptoms with antibiotic therapy. The clinical presentation, diagnostic challenges, and differentiation from other neurological conditions are discussed. This case underscores the importance of considering neurobrucellosis in regions where brucellosis is prevalent and highlights this rare neurological complication’s distinctive clinical and radiological features. Early recognition and appropriate treatment are crucial to mitigate the significant morbidity associated with neurobrucellosis.
Læs mere Tjek på PubMedThomas C. G. BoschMark WigleyBeatriz ColominaBrendan BohannanForrest MeggersKatherine R. AmatoMeghan B. AzadMartin J. BlaserKate BrownMaria Gloria Dominguez-BelloStanislav Dusko EhrlichEran ElinavB. Brett FinlayKate GeddieNaama Geva-ZatorskyTamara Giles-VernickPhilippe GrosKaren GuilleminLouis-Patrick HaraouiElizabeth JohnsonFrédéric KeckJamie LorimerMargaret J. McFall-NgaiMark NichterSven PetterssonHendrik PoinarTobias ReesCarolina TropiniEduardo A. UndurragaLiping ZhaoMelissa K. MelbyaZoological Institute, University of Kiel, Kiel 24118, GermanybHumans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, CanadacGraduate School of Architecture, Planning and Preservation, Columbia University, New York, NY 10027dSchool of Architecture, Princeton University, Princeton, NJ 08544eThe Institute of Ecology and Evolution, University of Oregon, Eugene, OR 97403-5289fPrinceton University School of Architecture & Andlinger Center for Energy and the Environment, Princeton, NJ 08540gDepartment of Anthropology, Northwestern University, Evanston, IL 60208hDepartment of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB R3E 0Z3, CanadaiDepartment of Community Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P5, CanadajChildren’s Hospital Research Institute of Manitoba, Winnipeg, MB R3E 3P4, CanadakCenter for Advanced Biotechnology and Medicine at Rutgers Biomedical and Health Sciences, Rutgers University, Piscataway, NJ 08854-8021lProgram in Science, Technology and Society, Massachusetts Institute of Technology, Cambridge, MA 02139mDepartment of Biochemistry and Microbiology, Rutgers University, New Brunswick, NJ 08901nDepartment of Anthropology, Rutgers University, New Brunswick, NJ 08901oInstitute of Neurology, University College London, London WC1N 3RX, United KingdompSystems Immunology Department, Weizmann Institute of Science, Rehovot 761000, IsraelqDivision of Microbiome & Cancer, Deutsches Krebsforschungszentrum, 69120 Heidelberg, GermanyrMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, CanadasMedical and Related Sciences Centre, The Canadian Institute for Advanced Research, Toronto, ON M5G 1L7, CanadatTechnion Integrated Cancer Center, Technion-Israel Institute of Technology, Haifa 3525433, IsraeluDepartment of Cell Biology and Cancer Science, Technion-Israel Institute of Technology, Haifa 3525433, IsraelvAnthropology & Ecology of Disease Emergence, Institut Pasteur, Université Paris Cité, Paris 75015, FrancewDepartment of Biochemistry, McGill University, Montreal, QC H3G 1Y6, CanadaxInstitute of Molecular Biology, University of Oregon, Eugene, OR 97403yDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Canada J1E 4K8zCollege of Human Ecology, Cornell University, Ithaka NY 14853aaLaboratoire d’Anthropologie Sociale, Collège de France, Paris 75005, FrancebbSchool of Geography and the Environment, University of Oxford, OX1 3QY, United KingdomccDivision of Biology and Biological Engineering, Caltech, Pasadena, CA 91125ddSchool of Anthropology, University of Arizona, Tucson, AZ 85721eeNanyang Technological University, Singapore 637715, SingaporeffDepartment of Anthropology, McMaster University, Hamilton, ON L8S 4M4, CanadaggLIMN, Berkeley, CA 94708hhDepartment of Microbiology and Immunology and School of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 1Z3, CanadaiiEscuela de Gobierno, Pontificia Universidad Católica de Chile, Santiago 7820436, ChilejjDepartment of Anthropology, University of Delaware, Newark, DE 19716
Proceedings of the National Academy of Sciences, 15.05.2024
Tilføjet 15.05.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 20, May 2024.
Læs mere Tjek på PubMedAmy McDermott
Proceedings of the National Academy of Sciences, 15.05.2024
Tilføjet 15.05.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 20, May 2024.
Læs mere Tjek på PubMedLawanya NatarajanMaria Laura De SciscioAlessandro Nicola NardiAshok SekharAlessandra Del GiudiceMarco D’AbramoAthi N. NaganathanaDepartment of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, IndiabDepartment of Chemistry, Sapienza University of Rome, Rome 00185, ItalycMolecular Biophysics Unit, Indian Institute of Science Bangalore, Bengaluru 560 012, India
Proceedings of the National Academy of Sciences, 15.05.2024
Tilføjet 15.05.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 20, May 2024.
Læs mere Tjek på PubMedMaryam KohramAmy E. SandersonAlicia LouiPeyton V. ThompsonHarsh VashisthaAseel ShomarZoltán N. OltvaiHanna SalmanaDepartment of Physics and Astronomy, University of Pittsburgh, Pittsburgh, PA 15260bDepartment of Pathology, University of Pittsburgh, Pittsburgh, PA 15260cDepartment of Chemical Engineering, Technion–Israel Institute of Technology, Haifa 32000, IsraeldDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA 15260eDepartment of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY 14627
Proceedings of the National Academy of Sciences, 15.05.2024
Tilføjet 15.05.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 20, May 2024.
Læs mere Tjek på PubMedJiewen ChenXiyuan LiuYi ZouJunli GongZhenhuang GeXiaorong LinWei ZhangHongyan HuangJianli ZhaoPhei Er SawYongjun LuHai HuErwei SongaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, ChinabBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, ChinacDepartment of Breast Medicine, Affiliated Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan 528000, ChinadRun-ze Laboratory for Gastrointestinal Microbiome Study, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510275, ChinaeDiagnosis and Treatment Center of Breast Diseases, Shantou Central Hospital, Shantou 515000, ChinafDepartment of Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, ChinagDepartment of Breast Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
Proceedings of the National Academy of Sciences, 15.05.2024
Tilføjet 15.05.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 20, May 2024.
Læs mere Tjek på PubMedAlberto Torcello-RequenaAndrew R. J. MurphyIan D. E. A. LidburyFrances D. PittRichard StarkAndrew D. MillardRichard J. PuxtyYin ChenDavid J. ScanlanaSchool of Life Sciences, University of Warwick, Coventry CV4 7AL, United KingdombMolecular Microbiology: Biochemistry to Disease, School of Biosciences, University of Sheffield, Sheffield S10 2TN, United KingdomcCentre for Phage Research, Department of Genetics and Genome Biology, University of Leicester, Leicester LE1 7RH, United KingdomdSchool of Biosciences, University of Birmingham, Birmingham B15 2TT, United Kingdom
Proceedings of the National Academy of Sciences, 15.05.2024
Tilføjet 15.05.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 20, May 2024.
Læs mere Tjek på PubMedTaylor N. SzyszkaMichael P. AndreasFelicia LieLohra M. MillerLachlan S. R. AdamsonFarzad FatehiReidun TwarockBenjamin E. DraperMartin F. JarroldTobias W. GiessenYu Heng LauaSchool of Chemistry, The University of Sydney, Camperdown, NSW 2006, AustraliabThe University of Sydney Nano Institute, The University of Sydney, Camperdown, NSW 2006, AustraliacDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109dChemistry Department, Indiana University, Bloomington, IN 47405eDepartment of Mathematics, University of York, York YO10 5DD, United KingdomfYork Cross-Disciplinary Centre for Systems Analysis, University of York, York YO10 5DD, United KingdomgDepartment of Biology, University of York, York YO10 5DD, United KingdomhMegadalton Solutions Inc., Bloomington, IN 47401
Proceedings of the National Academy of Sciences, 15.05.2024
Tilføjet 15.05.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 20, May 2024.
Læs mere Tjek på PubMedTianyi MaJeremy RothschildFaisal HalabeyaAnton ZilmanJoshua N. MilsteinaDepartment of Physics, University of Toronto, Toronto, ON M5S 3J1, CanadabDepartment of Chemical and Physical Sciences, University of Toronto, Mississauga, ON L5L 1C6, Canada
Proceedings of the National Academy of Sciences, 15.05.2024
Tilføjet 15.05.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 20, May 2024.
Læs mere Tjek på PubMedMaryann MoralesMoon Young YangWilliam A. GoddardHarry B. GrayJay R. WinkleraBeckman Institute, California Institute of Technology, Pasadena, CA 91125
Proceedings of the National Academy of Sciences, 15.05.2024
Tilføjet 15.05.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 20, May 2024.
Læs mere Tjek på PubMedClinical Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Abstract SARS-CoV-2 is predominantly transmitted through aerosols (i.e., airborne transmission), however, the US Centers for Disease Control and Prevention continue to recommend the use of contact precautions (a gown and gloves) for the care of patients with COVID-19. Infection prevention guidelines should reflect the current science and eliminate this wasteful practice.
Læs mere Tjek på PubMedClinical Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Abstract Outpatient parenteral antimicrobial therapy (OPAT) relies on substantial uncompensated provider time. In this study of a large academic OPAT program, the median amount of unbilled OPAT management time was 27 minutes per week, per OPAT course. These data should inform benchmarks in pursuing novel payment approaches for OPAT.
Læs mere Tjek på PubMedClinical Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Abstract Background Antibiotics are a strong risk factor for Clostridioides difficile infection (CDI), and CDI incidence is often measured as an important outcome metric for antimicrobial stewardship interventions aiming to reduce antibiotic use. However, risk of CDI from antibiotics varies by agent and dependent on the intensity (i.e., spectrum and duration) of antibiotic therapy. Thus, the impact of stewardship interventions on CDI incidence is variable, and understanding this risk requires a more granular measure of intensity of therapy than traditionally used measures like days of therapy (DOT).Methods We performed a retrospective cohort study to measure the independent association between intensity of antibiotic therapy, as measured by the antibiotic spectrum index (ASI), and hospital-associated CDI (HA-CDI) at a large academic medical center between January 2018 and March 2020. We constructed a marginal Poisson regression model to generate adjusted relative risks for a unit increase in ASI per antibiotic day.Results We included 35,457 inpatient encounters in our cohort. Sixty-eight percent of patients received at least one antibiotic. We identified 128 HA-CDI cases, which corresponds to an incidence rate of 4.1 cases per 10,000 patient-days. After adjusting for known confounders, each additional unit increase in ASI per antibiotic day is associated with 1.09 times the risk of HA-CDI (Relative Risk = 1.09, 95% Confidence Interval: 1.06 to 1.13).Conclusions ASI was strongly associated with HA-CDI and could be a useful tool in evaluating the impact of antibiotic stewardship on HA-CDI rates, providing more granular information than the more commonly used days of therapy.
Læs mere Tjek på PubMedClinical Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Abstract Background Environmental disinfection is essential for reducing spread of healthcare associated infections (HAIs). Previous studies report conflicting results regarding the effects of ultraviolet light (UV) in reducing infections. This trial evaluated the impact of adding pulsed xenon UV (PX-UV) to standard terminal cleaning in reducing environmentally-implicated HAIs (eiHAIs).Methods The LAMP trial was conducted in 2 hospitals (15 inpatient wards) utilizing a cluster randomized controlled, double-blinded, interventional crossover trial comparing standard terminal cleaning followed by either pulsed xenon ultraviolet (PX-UV) disinfection (intervention arm) or sham disinfection (control arm). The primary outcome was incidence of eiHAIs from clinical microbiology tests on the 4th day of stay or later or within 3 days after discharge from the study unit. EiHAIs included clinical cultures positive for vancomycin-resistant enterococci (VRE), extended spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia, methicillin-resistant Staphylococcus aureus (MRSA), and Acinetobacter baumannii, and stool PCR positive for Clostridiodes difficile.Findings Between May 18, 2017 to Jan 7, 2020, 25,732 patients were included, with an incidence of 601 eiHAI and 180,954 patient days. There was no difference in the rate of eiHAIs in the intervention and sham arms (3.49 vs 3.17 infections/1000 patient days respectively, RR 1.10 CI (0.94, 1.29, p= 0.23)). Study results were similar when stratified by eiHAI type, hospital, and unit type.Conclusion The LAMP study failed to demonstrate an effect of the addition of UV light disinfection following terminal cleaning on reductions in rates of eiHAIs. Further investigations targeting hospital environmental surfaces and the role of no touch technology to reduce HAIs are needed.
Læs mere Tjek på PubMedClinical Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Clinical Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Abstract In a large, multi-regional cohort of African infants with HIV exposure, 44% of those with a positive HIV PCR lacked a confirmatory positive test. Efforts are needed to ensure high-fidelity implementation of HIV testing algorithms, so that all positive results are confirmed thereby reducing the risk of potentially false-positive results.
Læs mere Tjek på PubMedInfectious Disease Modelling, 15.05.2024
Tilføjet 15.05.2024
Publication date: Available online 15 May 2024 Source: Infectious Disease Modelling Author(s): Gilberto Gonzalez-Parra, Md Shahriar Mahmud, Claus Kadelka
Læs mere Tjek på PubMedInfectious Disease Modelling, 15.05.2024
Tilføjet 15.05.2024
Publication date: Available online 14 May 2024 Source: Infectious Disease Modelling Author(s): Junyuan Yang, Sijin Wu, Xuezhi Li, Xiaoyan Wang, Xue-Song Zhang, Lu Hou
Læs mere Tjek på PubMedAraceli Tepale-Segura, Julián A. Gajón, Samira Muñoz-Cruz, Octavio Castro-Escamilla, Laura C. Bonifaz
Frontiers in Immunology, 15.05.2024
Tilføjet 15.05.2024
IntroductionInnate immune training is a metabolic, functional, and epigenetic long-term reprogramming of innate cells triggered by different stimuli. This imprinting also reaches hematopoietic precursors in the bone marrow to sustain a memory-like phenotype. Dendritic cells (DCs) can exhibit memory-like responses, enhanced upon subsequent exposure to a pathogen; however, whether this imprinting is lineage and stimulus-restricted is still being determined. Nevertheless, the functional consequences of DCs training on the adaptive and protective immune response against non-infectious diseases remain unresolved.MethodsWe evaluated the effect of the nontoxic cholera B subunit (CTB), LPS and LTA in the induction of trained immunity in murine DCs revealed by TNFa and LDH expression, through confocal microscopy. Additionally, we obtained bone marrow DCs (BMDCs) from mice treated with CTB, LPS, and LTA and evaluated training features in DCs and their antigen-presenting cell capability using multiparametric cytometry. Finally, we design an experimental melanoma mouse model to demonstrate protection induced by CTB-trained DCs in vivo.ResultsCTB-trained DCs exhibit increased expression of TNFa, and metabolic reprogramming indicated by LDH expression. Moreover, CTB training has an imprint on DC precursors, increasing the number and antigen-presenting function in BMDCs. We found that training by CTB stimulates the recruitment of DC precursors and DCs infiltration at the skin and lymph nodes. Interestingly, training-induced by CTB promotes a highly co-stimulatory phenotype in tumor-infiltrating DCs (CD86+) and a heightened functionality of exhausted CD8 T cells (Ki67+, GZMB+), which were associated with a protective response against melanoma challenge in vivo.ConclusionOur work indicates that CTB can induce innate immune training on DCs, which turns into an efficient adaptive immune response in the melanoma model and might be a potential immunotherapeutic approach for tumor growth control.
Læs mere Tjek på PubMedJoo‐Hee Hwang, Jeong‐Hwan Hwang
Journal of Medical Virology, 15.05.2024
Tilføjet 15.05.2024
Gabrielle de Crombrugghe, Anne Botteaux, Joshua Osowicki, Andrew C. Steer, Pierre R. Smeesters
Clinical Microbiology and Infection, 15.05.2024
Tilføjet 15.05.2024
To test the prevailing dogma that S. pyogenes emm-types that cause pharyngitis are the same as those associated with carriage, using a global dataset.
Læs mere Tjek på PubMedNicholas M. Anstey, Wai-Hong Tham, G. Dennis Shanks, Jeanne R. Poespoprodjo, Bruce M. Russell, Steven Kho
Trends in Parasitology, 15.05.2024
Tilføjet 15.05.2024
Plasmodium vivax contributes significantly to global malaria morbidity. Key advances include the discovery of pathways facilitating invasion by P. vivax merozoites of nascent reticulocytes, crucial for vaccine development. Humanized mouse models and hepatocyte culture systems have enhanced understanding of hypnozoite biology. The spleen has emerged as a major reservoir for asexual vivax parasites, replicating in an endosplenic life cycle, and contributing to recurrent and chronic infections, systemic inflammation, and anemia. Splenic accumulation of uninfected red cells is the predominant cause of anemia. Recurring and chronic infections cause progressive anemia, malnutrition, and death in young children in high-transmission regions. Endothelial activation likely contributes to vivax-associated organ dysfunction. The many recent advances in vivax pathobiology should help guide new approaches to prevention and management.
Læs mere Tjek på PubMedCaroline Lin Lin Chua, Raika Francesca Morales, Po Ying Chia, Tsin Wen Yeo, Andrew Teo
Trends in Microbiology, 15.05.2024
Tilføjet 15.05.2024
Dengue is a mosquito-borne viral disease which causes significant morbidity and mortality each year. Previous research has proposed several mechanisms of pathogenicity that mainly involve the dengue virus and host humoral immunity. However, innate immune cells, such as neutrophils, may also play an important role in dengue, albeit a much less defined role. In this review, we discuss the emerging roles of neutrophils in dengue and their involvement in pathologies associated with severe dengue. We also describe the potential use of several neutrophil proteins as biomarkers for severe dengue. These studies suggest that neutrophils are important players in dengue, and a better understanding of neutrophil-dengue biology is urgently needed.
Læs mere Tjek på PubMedAllison P. Pack, Mary Clare Masters, Rachel O’Conor, Kenya Alcantara, Sophia Svoboda, Reneaki Smith, Fangyu Yeh, Guisselle Wismer, Amisha Wallia, Stacy C. Bailey
PLoS One Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
by Allison P. Pack, Mary Clare Masters, Rachel O’Conor, Kenya Alcantara, Sophia Svoboda, Reneaki Smith, Fangyu Yeh, Guisselle Wismer, Amisha Wallia, Stacy C. Bailey Background Older adults with HIV are at increased risk of developing certain chronic health conditions including type 2 diabetes mellitus (T2DM). As the number and complexity of conditions increases, so do treatment and health care needs. We explored patient and clinician preferences for HIV+T2DM care and perceived solutions to improving care. Methods We conducted an exploratory qualitative study comprised of individual in-depth interviews. Participants included English-speaking patients aged 50 and older living with HIV and T2DM and infectious disease (ID) and primary care (PC) clinicians from a large academic health center in Chicago. Thematic analysis drew from the Framework Method. Results A total of 19 patient and 10 clinician participants were interviewed. Many patients reported seeking HIV and T2DM care from the same clinician; they valued rapport and a ‘one-stop-shop’. Others reported having separate clinicians; they valued perceived expertise and specialty care. Nearly all clinicians reported comfort screening for T2DM and initiating first line oral therapy; ID clinicians reported placing referrals for newer, complex therapies. Patients would like educational support for T2DM management; clinicians would like to learn more about newer therapies and easier referral processes. Conclusions Patient-centered care includes managing T2DM from a variety of clinical settings for individuals with HIV, yet strategies are needed to better support clinicians. Future research should examine how best to implement these strategies.
Læs mere Tjek på PubMedFatou Ndiaye, Abdoulaye Diop, Joseph Chabi, Katherine Sturm-Ramirez, Massila Senghor, El Hadji Diouf, Badara Samb, Seynabou Mocote Diedhiou, Omar Thiaw, Sarah Zohdy, Ellen Dotson, Doudou Sene, Mame Birame Diouf, Valerie Koscelnik, Lilia Gerberg, Abdoulaye Bangoura, Tiffany Clark, Ousmane Faye, Ibrahima Dia, Lassana Konate, El Hadji Amadou Niang
PLoS One Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
by Fatou Ndiaye, Abdoulaye Diop, Joseph Chabi, Katherine Sturm-Ramirez, Massila Senghor, El Hadji Diouf, Badara Samb, Seynabou Mocote Diedhiou, Omar Thiaw, Sarah Zohdy, Ellen Dotson, Doudou Sene, Mame Birame Diouf, Valerie Koscelnik, Lilia Gerberg, Abdoulaye Bangoura, Tiffany Clark, Ousmane Faye, Ibrahima Dia, Lassana Konate, El Hadji Amadou Niang Urban malaria has become a challenge for most African countries due to urbanization, with increasing population sizes, overcrowding, and movement into cities from rural localities. The rapid expansion of cities with inappropriate water drainage systems, abundance of water storage habitats, coupled with recurrent flooding represents a concern for water-associated vector borne diseases, including malaria. This situation could threaten progress made towards malaria elimination in sub-Saharan countries, including Senegal, where urban malaria has presented as a threat to national elimination gains. To assess drivers of urban malaria in Senegal, a 5-month study was carried out from August to December 2019 in three major urban areas and hotspots for malaria incidence (Diourbel, Touba, and Kaolack) including the rainy season (August-October) and partly dry season (November–December). The aim was to characterize malaria vector larval habitats, vector dynamics across both seasons, and to identify the primary eco- environmental entomological factors contributing to observed urban malaria transmission. A total of 145 Anopheles larval habitats were found, mapped, and monitored monthly. This included 32 in Diourbel, 83 in Touba, and 30 in Kaolack. The number of larval habitats fluctuated seasonally, with a decrease during the dry season. In Diourbel, 22 of the 32 monitored larval habitats (68.75%) were dried out by December and considered temporary, while the remaining 10 (31.25%) were classified as permanent. In the city of Touba 28 (33.73%) were temporary habitats, and of those 57%, 71% and 100% dried up respectively by October, November, and December. However, 55 (66.27%) habitats were permanent water storage basins which persisted throughout the study. In Kaolack, 12 (40%) permanent and 18 (60%) temporary Anopheles larval habitats were found and monitored during the study. Three malaria vectors (An. arabiensis, An. pharoensis and An. funestus s.l.) were found across the surveyed larval habitats, and An. arabiensis was found in all three cities and was the only species found in the city of Diourbel, while An. arabiensis, An. pharoensis, and An. funestus s.l. were detected in the cities of Touba and Kaolack. The spatiotemporal observations of immature malaria vectors in Senegal provide evidence of permanent productive malaria vector larval habitats year-round in three major urban centers in Senegal, which may be driving high urban malaria incidence. This study aimed to assess the presence and type of anopheline larvae habitats in urban areas. The preliminary data will better inform subsequent detailed additional studies and seasonally appropriate, cost-effective, and sustainable larval source management (LSM) strategies by the National Malaria Control Programme (NMCP).
Læs mere Tjek på PubMedMehrdad Khezri, Courtney McKnight, Chenziheng Allen Weng, Sarah Kimball, Don Des Jarlais
PLoS One Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
by Mehrdad Khezri, Courtney McKnight, Chenziheng Allen Weng, Sarah Kimball, Don Des Jarlais Background Persons who inject drugs (PWID) may be unengaged with healthcare services and face an elevated risk of severe morbidity and mortality associated with COVID-19 due to chronic diseases and structural inequities. However, data on COVID-19 vaccine uptake, particularly booster vaccination, among PWID are limited. We examined COVID-19 vaccine uptake and factors associated with booster vaccination among PWID in New York City (NYC). Methods We recruited PWID using respondent-driven sampling from October 2021 to November 2023 in a survey that included HIV and SARS-CoV-2 antibodies testing. The questionnaire included demographics, COVID-19 vaccination and attitudes, and drug use behaviors. Results Of 436 PWID, 80% received at least one COVID-19 vaccine dose. Among individuals who received at least one COVID-19 vaccine dose, 95% were fully vaccinated. After excluding participants recruited before booster authorization for general adults started in NYC, and those who had never received an initial vaccination, 41% reported having received a COVID-19 booster vaccine dose. COVID-19 booster vaccination was significantly associated with having a high school diploma or GED (adjusted odds ratio (aOR) 1.93; 95% confidence interval (CI) 1.09, 3.48), ever received the hepatitis A/B vaccine (aOR 2.23; 95% CI 1.27, 3.96), main drug use other than heroin/speedball, fentanyl and stimulants (aOR 14.4; 95% CI 2.32, 280), number of non-fatal overdoses (aOR 0.35; 95% CI 0.16, 0.70), and mean vaccination attitude score (aOR 0.94; 95% CI 0.89, 0.98). Conclusions We found a suboptimal level of COVID-19 booster vaccination among PWID, which was consistent with the rates observed in the general population in NYC and the U.S. Community-based interventions are needed to improve COVID-19 booster vaccination access and uptake among PWID. Attitudes towards vaccination were significant predictors of both primary and booster vaccination uptake. Outreach efforts focusing on improving attitudes towards vaccination and educational programs are essential for reducing hesitancy and increasing booster vaccination uptake among PWID.
Læs mere Tjek på PubMedNaoki Watanabe, Tomohisa Watari, Yoshihito Otsuka, Masahiko Ito, Kazufumi Yamagata, Miyuki Fujioka
PLoS One Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
by Naoki Watanabe, Tomohisa Watari, Yoshihito Otsuka, Masahiko Ito, Kazufumi Yamagata, Miyuki Fujioka Introduction The study of Klebsiella quasipneumoniae, Klebsiella variicola, and AmpC production in extended-spectrum β-lactamase (ESBL)-producing Klebsiella in Japan is limited, and existing data are insufficient. This study aims to characterize Klebsiella species, determine AmpC production rates, and analyze antimicrobial resistance patterns in ESBL-producing Klebsiella isolates in Japan. Methods A total of 139 clinical isolates of ESBL-producing Klebsiella were collected in Japan, along with their corresponding antimicrobial susceptibility profiles. The isolates were identified using a web-based tool. ESBL genes within the isolates were identified using multiplex PCR. Screening for AmpC-producing isolates was performed using cefoxitin disks, followed by multiplex PCR to detect the presence of AmpC genes. Antimicrobial resistance patterns were analyzed across the predominant ESBL genotypes. Results The web-based tool identified 135 isolates (97.1%) as Klebsiella pneumoniae and 4 (2.9%) as K. quasipneumoniae subsp. similipneumoniae, with no instances of K. variicola detected. Among K. pneumoniae, the CTX-M-1 group emerged as the predominant genotype (83/135, 61.5%), followed by K. quasipneumoniae subsp. similipneumoniae (3/4, 75.0%). The CTX-M-9 group was the second most prevalent genotype in K. pneumoniae (45/135, 33.3%). The high resistance rates were observed for quinolones (ranging from 46.7% to 63.0%) and trimethoprim/sulfamethoxazole (78.5%). The CTX-M-1 group exhibited higher resistance to ciprofloxacin (66/83, 79.5%) compared to the CTX-M-9 group (18/45, 40.0%), a trend also observed for levofloxacin and trimethoprim/sulfamethoxazole. Among the 16 isolates that tested positive during AmpC screening, only one K. pneumoniae isolates (0.7%) were confirmed to carry the AmpC gene. Conclusion Klebsiella pneumoniae with the CTX-M-1 group is the most common ESBL-producing Klebsiella in Japan and showed a low proportion of AmpC production. These isolates are resistant to quinolones and trimethoprim/sulfamethoxazole, highlighting the challenge of managing this pathogen. The findings underscore the importance of broader research and continuous monitoring to address the resistance patterns of ESBL-producing Klebsiella.
Læs mere Tjek på PubMedMoon-Beom Kim, Su-Min Park, Ga-Hyun Lim, Yong-Hun Oh, Kyung-Won Seo, Hwa-Young Youn
PLoS One Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
by Moon-Beom Kim, Su-Min Park, Ga-Hyun Lim, Yong-Hun Oh, Kyung-Won Seo, Hwa-Young Youn Superoxide dismutase (SOD) is an antioxidant enzyme that protects the body from free radicals. It has both antioxidant and immunomodulatory properties, inducing macrophage polarization from M1 to M2. Macrophages, key mediators of the innate immune response, are divided into the M1 (pro-inflammatory) and M2 (anti-inflammatory) subtypes. In this study, we aimed to assess the antioxidant and neuroprotective effects of SOD on nerve cells and its immunomodulatory effects on macrophages. We observed that SOD inhibited the accumulation of reactive oxygen species and enhanced the viability of H2O2-treated nerve cells. Furthermore, SOD reduced the degree of necrosis in nerve cells treated with the conditioned medium from macrophages, which induced inflammation. In addition, SOD promoted the M1 to M2 transition of macrophages. Our findings suggest that SOD protects nerve cells and regulates immune responses.
Læs mere Tjek på PubMedBeminate Lemma Seifu, Getayeneh Antehunegn Tesema, Bezawit Melak Fentie, Tirualem Zeleke Yehuala, Abdulkerim Hassen Moloro, Kusse Urmale Mare
PLoS One Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
by Beminate Lemma Seifu, Getayeneh Antehunegn Tesema, Bezawit Melak Fentie, Tirualem Zeleke Yehuala, Abdulkerim Hassen Moloro, Kusse Urmale Mare Introduction Childhood stunting is a global public health concern, associated with both short and long-term consequences, including high child morbidity and mortality, poor development and learning capacity, increased vulnerability for infectious and non-infectious disease. The prevalence of stunting varies significantly throughout Ethiopian regions. Therefore, this study aimed to assess the geographical variation in predictors of stunting among children under the age of five in Ethiopia using 2019 Ethiopian Demographic and Health Survey. Method The current analysis was based on data from the 2019 mini Ethiopian Demographic and Health Survey (EDHS). A total of 5,490 children under the age of five were included in the weighted sample. Descriptive and inferential analysis was done using STATA 17. For the spatial analysis, ArcGIS 10.7 were used. Spatial regression was used to identify the variables associated with stunting hotspots, and adjusted R2 and Corrected Akaike Information Criteria (AICc) were used to compare the models. As the prevalence of stunting was over 10%, a multilevel robust Poisson regression was conducted. In the bivariable analysis, variables having a p-value < 0.2 were considered for the multivariable analysis. In the multivariable multilevel robust Poisson regression analysis, the adjusted prevalence ratio with the 95% confidence interval is presented to show the statistical significance and strength of the association. Result The prevalence of stunting was 33.58% (95%CI: 32.34%, 34.84%) with a clustered geographic pattern (Moran’s I = 0.40, p40 (APR = 0.74, 95%CI: 0.55, 0.99). Children whose mother had secondary (APR = 0.74, 95%CI: 0.60, 0.91) and higher (APR = 0.61, 95%CI: 0.44, 0.84) educational status, household wealth status (APR = 0.87, 95%CI: 0.76, 0.99), child aged 6–23 months (APR = 1.87, 95%CI: 1.53, 2.28) were all significantly associated with stunting. Conclusion In Ethiopia, under-five children suffering from stunting have been found to exhibit a spatially clustered pattern. Maternal education, wealth index, birth interval and child age were determining factors of spatial variation of stunting. As a result, a detailed map of stunting hotspots and determinants among children under the age of five aid program planners and decision-makers in designing targeted public health measures.
Læs mere Tjek på PubMedStefanie Reiter, Ting Sun, Sabine Gärtner, Stefan Pöhlmann, Michael Winkler
PLoS One Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
by Stefanie Reiter, Ting Sun, Sabine Gärtner, Stefan Pöhlmann, Michael Winkler Non-human primate (NHP)-based model systems are highly relevant for biomedical research. However, only few NHP cell lines are available and the generation of additional cell lines is an urgent need to help in the refinement and replacement of these models. Using lentiviral transduction of c-Fos, we established cell lines from the brain of rhesus macaques (Macaca mulatta). Transcriptome analysis revealed that these cell lines are closely related to astrocytes, which was confirmed by immunoblot and immunofluorescence microscopy detecting expression of the astrocyte marker glial fibrillary acidic protein (GFAP). Quantitative real-time PCR (qRT-PCR) demonstrated that major pathways of the interferon (IFN) system are intact. Using retroviral pseudotypes we found that the cell lines are susceptible to entry driven by the glycoproteins of vesicular stomatitis virus (VSV), lymphocytic choriomeningitis virus (LCMV) and to a lesser extent influenza A virus (IAV). Finally, these cells supported growth of Zika virus (ZIKV) and Papiine alphaherpesvirus 2 (PaHV2). In summary, we developed IFN-responsive cell lines from the rhesus macaque brain that allowed entry driven by several viral glycoproteins and were permissive to infection with ZIKV and a primate simplexvirus. These cell lines will be useful for efforts to analyze neurotropic viral infections in rhesus macaque models.
Læs mere Tjek på PubMedJun LuoMin LiuWen AiXiaoling ZhengShaowei LiuKuo HuangChanglin ZhangQianyuan LiChunhua Luo1The First College of Clinical Medical Science, China Three Gorges University, Yichang, China2Yichang Central People’s Hospital, Yichang, China, Laurent Poirel
Antimicrobial Agents And Chemotherapy, 15.05.2024
Tilføjet 15.05.2024
Jin Soo ShinYejin JangDong-Su KimEunhye JungMyoung Kyu LeeByungil KimSunjoo AhnYeonju ShinSu San JangChang Soo YunJongman YooYoung Chang LimSoo Bong HanMeehyein Kim1Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea2Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea3CHA Organoid Research Center, CHA University, Seongnam, Gyeonggi-do, Republic of Korea4Department of Otorhinolaryngology-Head and Neck Surgery, The Research Institute, Konkuk University School of Medicine, Seoul, Republic of Korea5Medicinal Chemistry and Pharmacology, University of Science and Technology (UST), Daejeon, Republic of Korea, Miguel Angel Martinez
Antimicrobial Agents And Chemotherapy, 15.05.2024
Tilføjet 15.05.2024
Miran TangZhuocheng YaoYan LiuZhexiao MaDeyi ZhaoZhenzhi MaoYue WangLijiang ChenTieli Zhou1Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China2School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China, Pranita D. Tamma
Antimicrobial Agents And Chemotherapy, 15.05.2024
Tilføjet 15.05.2024
Journal of Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Journal of Infectious Diseases, 15.05.2024
Tilføjet 15.05.2024
Abstract Background The extent to which infections may have been undetected in an epicenter of the 2022 mpox outbreak is unknown.Methods A serosurvey (July and August 2022) assessed the seroprevalence and correlates of mpox infection among a diverse sample of asymptomatic patients with no prior mpox diagnoses and no known histories of smallpox or mpox vaccination. We present seropositivity stratified by participant characteristics collected via survey.Results Two-thirds of 419 participants were cismen (281 of 419), of whom 59.1% (166 of 281) reported sex with men (MSM). The sample also included 109 ciswomen and 28 transgender/gender nonconforming/nonbinary individuals. Overall seroprevalence was 6.4% (95% confidence interval [CI], 4.1%–8.8%); 3.7% among ciswomen (95% CI, 1.0%–9.1%), 7.0% among cismen with only ciswomen partners (95% CI, 2.0%–11.9%), and 7.8% among MSM (95% CI, 3.7%–11.9%). There was little variation in seroprevalence by race/ethnicity, age group, HIV status, or number of recent sex partners. No participants who reported close contact with mpox cases were seropositive. Among participants without recent mpox-like symptoms, 6.3% were seropositive (95% CI, 3.6%–9.0%).Conclusions Approximately 1 in 15 vaccine-naive people in our study had antibodies to mpox during the height of the NYC outbreak, indicating the presence of asymptomatic infections that could contribute to ongoing transmission.
Læs mere Tjek på PubMed